Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report

• Ngā kaituhi matua: David Starks (Author), Deborah Prinz (Author), Amy Armstrong (Author), Lindsay Means (Author), Steven Waggoner (Author), Robert DeBernardo (Author)
• Hōputu: Pukapuka
• I whakaputaina: Hindawi Limited, 2011-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Type I hypersensitivity reactions to intravenous administration of etoposide are extremely rare. Etoposide is an essential component of several chemotherapy regimens used in gynecologic oncology, and discontinuation of this drug during a course of treatment should only be due to severe patient intol...